Consolidation Radiotherapy for Patients with Extended Disease Small Cell Lung Cancer in a Single Tertiary Institution: Impact of Dose and Perspectives in the Era of Immunotherapy

BACKGROUND: Consolidation radiotherapy (cRT) in extended disease small cell lung cancer (ED-SCLC) showed improved 2-year overall survival in patients who responded to chemotherapy (ChT) in CREST trial, however results of two meta - analysis were contradictive. Recently, immunotherapy was introduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanic, Karmen, Vrankar, Martina, But-Hadzic, Jasna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409599/
https://www.ncbi.nlm.nih.gov/pubmed/32726294
http://dx.doi.org/10.2478/raon-2020-0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409599/
https://www.ncbi.nlm.nih.gov/pubmed/32726294
http://dx.doi.org/10.2478/raon-2020-0046

Ejemplares similares